UNSPSC 51281511: Ethambutol dihydrochloride

This classification denotes an antitubercular agent with the molecular formula C10H24N2O2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QE4VW5FO07, chemically known as 1-butanol, 2,2'(1,2-ethanediyldiimino)bis-, dihydrochloride, (-(r*,r*)), but more generally known as ethambutol dihydrochloride, which bears US NIH Compound Identifier 3279. European Medicines Agency schedules ethambutol dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07271MIG.

Most nations, for tariff purposes, schedule ethambutol dihydrochloride under HS 29221980. SMILES: CC[C@@H](CO)NCCN[C@@H](CC)CO.CL.CL.

UNSPSC 51281511 Ethambutol dihydrochloride is a Commodity code representing pharmaceutical products, though recent state and local opportunities tagged to this code show a broader scope: emergency medical supplies, naloxone, and generic multi-source pharmaceuticals procured through competitive bidding and cooperative purchasing vehicles. State and local governments buying under this code include county health departments, state health and human services agencies, municipal fire departments, and multistate cooperative purchasing alliances. Issuing bodies solicit medical and pharmaceutical supplies through IFBs, RFPs, and RFIs, with vendors required to meet FDA compliance, cGMP certification where applicable, and Drug Supply Chain Security Act (DSCSA) standards. Recent opportunities demonstrate that procurement spans emergency response consumables (respiratory equipment, cardiac monitoring devices, gloves, bandaging materials) alongside prescription pharmaceuticals distributed through authorized wholesalers, indicating the code captures both acute-care supplies and longer-term pharmaceutical distribution networks.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response deadline July 26, 2023. The City of Tampa's Purchasing Department posted IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent SLBE bid discount capped at $10,000. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager relationships. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, and awards effective July 1, 2026, spanning Minnesota and Oregon. Vendors must maintain commercial general liability of $5,000,000 per occurrence and comply with performance penalties ranging from $200 to $1,500 per violation.